65,437 trials
Type 1 Diabetes Mellitus
Primary: Number of Participants With Glycemic Control (Glucose Levels Between 180-300 mg/dL) 24 to 100 Hours After Line Change — 17; 16 Participants — p=0.52
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Pre-bronchodilator Forced Expiratory Volume in First Second (FEV1) — 33; -25 mL — p=<0.0001
Anxiety Disorders
Primary: Change From Baseline in the Hamilton Rating Scale for Anxiety (HAM-A) Total Score — -10.9; -11.1; -11.5; -10.9 Units on scale
Schizophrenia
Primary: Number of Participants With Adverse Events — 19; 22; 18 participants
HIV Infections
Primary: HIV-RNA Levels — 0; 24; 10; 107 participants — p=<0.001
Hypertension
Primary: Change From Baseline in Mean Sitting Systolic Blood Pressure (MSSBP) — -15.4; -14.1 mm Hg
Chronic Obstructive Pulmonary Disease
Primary: Pre-bronchodilator Forced Expiratory Volume in First Second (FEV1) — 65; -16 mL — p=<0.0001
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Pre-bronchodilator Forced Expiratory Volume in First Second (FEV1) — 39; -10 mL — p=<0.0001
Pain
Primary: Patient Impressions at Final Visit (the Number of Participants Who Have Rated "Excellent" and "Good") — 70 Participants
Restless Legs Syndrome · Restless Legs Syndrome (RLS)
Primary: Adjusted Mean Change From Baseline in Wake Time During Sleep (WTDS) at Week 4/10 Measured by Polysomnography (PSG) (Sleep Study) Using Last Observation Carried Forward…
Genital Warts
Primary: Proportion of Subjects With Complete Clearance of All Warts (Both Presented at Baseline and Newly Emerged Warts) at End of Study — 0.191; 0.272; 0.103 participants
Iron Overload · Hereditary Hemochromatosis
Primary: Absolute Change of Serum Ferritin From Baseline to the End of Extension, by Dose Cohort (Extension Per-protocol Population) — -389.1; -610.5; -571.6 µg/L
Active Rheumatoid Arthritis
Primary: Double-blind Period: Mean Synovitis Scores at Baseline As Measured by the Rheumatoid Arthritis Clinical Trials 6 (OMERACT 6) Rheumatoid Arthritis Magnetic Resonance…
Healthy Volunteers
Primary: Incidence of Gastroduodenal Ulcers — 1.4; 27.6; 2.7 Percent — p=<0.0001
Diabetes Mellitus
Primary: Saxagliptin Area Under the Plasma Concentration Versus Time Curve From Time 0 Extrapolated to Infinity (AUC[0-inf]) — 107.28; 111.72; 103.35 ng*hr/mL